The clinical spectrum of Xanthogranulomatous pyelonephritis (XGP) is varied similar to its etiology. XGP was first described by Schlagenhaufer more than a century ago (1). Owing to its varied presentation, the differential diagnosis is also wide. It is a chronic pyelonephritis subtype in which destruction occurs to the renal parenchyma, resulting in progressive loss of kidney functions. Although middle age is the predominant age group affected, but it can be spotted at any age. XGP is usually unilateral; however, bilateral conditions have also been reported (2–4). The primary reason for XGP is obstructive pathology, which most commonly is nephrolithiasis. In children it can be secondary to congenital abnormalities of the kidney and urinary tract (5,6). The condition is usually seen in females and people having chronic comorbidity, such as diabetes and autoimmune diseases, or are on immunosuppressants (7–9). There is accumulation of macrophages (lipid-laden), leading to renal parenchymal destruction and fibrosis. The process of inflammation and damage could extend beyond the kidney and may involve surrounding structures. The kidney is usually nonfunctional, and surgical intervention in the form of nephrectomy is the only definitive treatment (10). In this study, we present our data of 15 patients who had undergone nephrectomy and had biopsy-proven XGP.

We present 15 patients of XGP, diagnosed on the basis of histopathologic findings. These patients constituted 4.53% of the 331 nephrectomies performed for infective causes over a period of 8 years at our center. All our patients had undergone unilateral total nephrectomy. All the patients consented for this study. Demographic and clinical records were analyzed after having consent from all the 15 patients. Specimens were fixed in 10% formalin and grossed. Paraffin-embedded sections were cut into 5-μm slices, followed by hematoxylin and eosin (H&E) staining. Sections were studied under light microscope in both low and high magnification.

The age range in our study was 18–65 years with a mean age of 43.93 ± 13.86 years. All patients underwent open procedure. Ten (66.6%) of our patients were females. Diabetes was present in 40% of the patients. Tables 1 and 2 show the clinical and biochemical parameters of the patients. None of our patients had bilateral disease. Flank pain in all cases and fever in 11 patients (73.3%) were the commonest symptoms reported at presentation. All the patients had undergone ultrasound examination, followed by contrast-enhanced computed tomography (CECT) and radioscintigraphy (diethylene triamine penta-acetic acid [DTPA] aerosol). Urine culture reports were positive in nine patients. Three patients had imaging suggestive of pyonephrosis, three had perinephric collection, and nine (60%) had concomitant nephrolithiasis. All the kidneys were grossly enlarged. None of our patients had a neoplastic lesion on biopsy. Figure 1 shows gross specimen of XGP kidney. Figures 2 and 3 show light microscopic findings on low and high power magnification, respectively.

XGP is a relatively rare subtype of chronic pyelonephritis with varying occurrences, which range between 0.6% and 1% as reported in literature (1). XGP is usually diffused (involving most of the kidney), and focal variant is less common. All age groups may be affected, but it is more commonly spotted in middle-age and elderly patients. XGP has been more commonly reported in females (11). Our study too observed that XGP is more common in females as compared to males. All the patients had unilateral presentation, as bilateral presentation is rarely encountered (2). Obstruction of the urinary tract and recurrent urinary tract infection (UTI) are common in XGP (1). A study conducted in India reported that nephrolithiasis was observed in 90% of XGP patients (12). Similarly, in our study nephrolithiasis was observed in nine (60%) patients. Diabetes mellitus, urinary stasis because of obstructive pathologies, renal neoplastic lesions, and immunocompromised attributes predispose patients to XGP (13,14). In the present study, diabetes was diagnosed in six (40%) patients and none of our patients was on immunosuppressive medications or had underlying malignancy. Varying clinical presentations have been observed in different studies. All the patients had abdominal pain on presentation, which is similar to most of the published series (7,12,14). In a recent study, pyonephrosis and perinephric abscess were observed in 25.0% and 7.5% patients, respectively (12), whereas in our study, three (20%) patients had pyonephrosis and three had perinephric collection. In a study conducted in Turkey, leukocytosis was observed in one (7.7%) patient, pyuria was diagnosed in six (46.1) patients, and 46.1% patients were anemic (15). Korkes et al. (5) analyzed 41 patients of XGP, in which anemia, pyuria, and leukocytosis were reported in 63%, 57.6%, and 41% of cases, respectively. In our study 11 (73.3%) patients were anemic, leucocystosis was diagnosed in 9 (60%), and all the patients had pyuria. In a study conducted by Kundu et al. (12), XGP was diffused in 31 (77.5%) patients and focal in 9 (22.5%) cases whereas in our study, diffused XGP was observed in 11 (73.3%) patients, which was similar to their study. Moreover, they observed biopsy diagnosis of XGP in 23 (57.5%) patients, 10 (25.0%) patients had pyonephrosis with XGP, 3 (7.5%) had XGP with diabetic nodular glomerulosclerosis, and 1 patient had renal cell carcinoma with concomitant XGP(12). In our study, pyonephrosis with XGP was noted in three patients whereas another three had perinephric collection. Diabetic glomerulosclerosis with XGP was observed in one of the six diabetic patients in our study, and none of our patients had neoplastic lesions. XGP has been divided into three stages: stage I is nephric XGP, which is confined to the renal parenchyma; stage II is perinephric XGP, having involvement of the anterior perirenal fascia, or Gerota’s fascia; and stage III is paranephric XGP, having involvement of the pararenal space and retroperitoneal structures (16). In the present study, 12 patients had stage I disease and 3 patients had stage II disease. Histopathologic examination of XGP determined an admixture of lipid-laden foamy macrophages with infiltration of varying mixtures of inflammatory cells along with fibrotic changes and cholesterol deposition. We too observed most of these changes in our specimens.

XGP is a form of chronic pyelonephritis, which, although less common, is devastating, because it causes destruction to the renal parenchyma and associated morbidity. Clinicoradiologic correlation, pertaining to both clinical and radiologic findings, cannot be overemphasized, and definitive diagnosis is established through histopathology.